Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

FDA clears TAVR guidewire built with BASILICA in mind
The Telltale system was designed to assist cardiologists when BASILICA is required prior to TAVR.
New technique could help when cardiologists repair 2 leaky heart valves at once
Performing M-TEER and T-TEER on the same patient using a single guide catheter appears to be both safe and effective. Researchers shared their experience with this approach in Circulation: Cardiovascular Interventions.
‘Strongest growth in over a decade’: Heart tech helps Medtronic beat earnings expectations
The company's PFA and TAVR technologies both played key roles in the successful second quarter. In addition, Medtronic expects its place in the renal denervation market to make a major impact going forward.
Did Boston Scientific pull the plug too early on TAVR devices? Cardiologists weigh in
Boston Scientific stopped selling its Acurate TAVR systems after they underperformed in a few key trials and failed to gain FDA approval. Was it the right call?
New physician Medicare payments for the Agent drug-coated balloon set for 2027
Boston Scientific said two category III CPT codes are set to become permanent category I codes for physician payments starting Jan. 1, 2027.

FFR measurements provide substantial value, help determine when patients need PCI

Patient outcomes are much better when clinicians use single-vessel FFR measurements to determine whether or not to perform PCI.

Boston Scientific gains FDA approval for Ranger drug-coated balloon

The newly approved solution was designed for the treatment of patients with PAD in the superficial femoral artery and proximal popliteal artery.

Advocates applaud legislation that would improve coverage for peripheral artery disease screening

If signed into law, the bill would improve coverage for screening for both Medicare and Medicaid beneficiaries.

MitraClip an effective bridge strategy for advanced heart failure patients waiting for a heart transplant

The findings were presented Friday, Oct. 16, at TCT Connect 2020.

PCI linked to higher all-cause mortality than CABG in new meta-analysis

The authors reviewed 23 different clinical trials—and more than 13,000 unique patients—for their research.

Intravascular lithotripsy ‘safely and effectively’ facilitates stent delivery for CAD patients

The findings were presented Thursday, Oct. 15, at TCT Connect 2020.

Bivalirudin bests heparin for treating heart attack patients undergoing PCI

The findings were presented Wednesday, Oct. 14, during TCT Connect 2020.

How to send more low-risk STEMI patients home early after PCI

Researchers developed and implemented a four-step process for identifying patients who can be discharged early following PCI.

Interventional Cardiology

FDA clears TAVR guidewire built with BASILICA in mind

New technique could help when cardiologists repair 2 leaky heart valves at once

‘Strongest growth in over a decade’: Heart tech helps Medtronic beat earnings expectations

Did Boston Scientific pull the plug too early on TAVR devices? Cardiologists weigh in

New physician Medicare payments for the Agent drug-coated balloon set for 2027